###begin article-title 0
Lhx2 Expression Promotes Self-Renewal of a Distinct Multipotential Hematopoietic Progenitor Cell in Embryonic Stem Cell-Derived Embryoid Bodies
###end article-title 0
###begin p 1
Conceived and designed the experiments: LC. Performed the experiments: LD KR AH. Analyzed the data: LC LD KR. Contributed reagents/materials/analysis tools: KR AH. Wrote the paper: LC LD KR.
###end p 1
###begin p 2
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2</italic>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 309 316 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2<sup>&#8722;/&#8722;</sup></italic>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
The molecular mechanisms regulating the expansion of the hematopoietic system including hematopoietic stem cells (HSCs) in the fetal liver during embryonic development are largely unknown. The LIM-homeobox gene Lhx2 is a candidate regulator of fetal hematopoiesis since it is expressed in the fetal liver and Lhx2-/- mice die in utero due to severe anemia. Moreover, expression of Lhx2 in embryonic stem (ES) cell-derived embryoid bodies (EBs) can lead to the generation of HSC-like cell lines. To further define the role of this transcription factor in hematopoietic regulation, we generated ES cell lines that enabled tet-inducible expression of Lhx2. Using this approach we observed that Lhx2 expression synergises with specific signalling pathways, resulting in increased frequency of colony forming cells in developing EB cells. The increase in growth factor-responsive progenitor cells directly correlates to the efficiency in generating HSC-like cell lines, suggesting that Lhx2 expression induce self-renewal of a distinct multipotential hematopoietic progenitor cell in EBs. Signalling via the c-kit tyrosine kinase receptor and the gp130 signal transducer by IL-6 is necessary and sufficient for the Lhx2 induced self-renewal. While inducing self-renewal of multipotential progenitor cells, expression of Lhx2 inhibited proliferation of primitive erythroid precursor cells and interfered with early ES cell commitment, indicating striking lineage specificity of this effect.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 289 292 289 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Harrison1">[1]</xref>
###xml 293 296 293 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Keller1">[3]</xref>
###xml 523 526 523 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Ikuta1">[4]</xref>
###xml 527 530 527 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Palis1">[7]</xref>
The mammalian hematopoietic system continuously generate large numbers of functional erythroid, myeloid and lymphoid cells throughout life. These functional cells originate from a small number of hematopoietic stem cells (HSCs) that are maintained by a process referred to as self-renewal [1]-[3]. The molecular basis for the differentiation and self-renewal processes is largely unknown. However, the hematopoietic system including the HSCs undergoes a rapid and strictly controlled expansion during embryonic development [4]-[7], suggesting that molecular and cellular analyses of the embryonic hematopoietic system would offer insights into these processes.
###end p 4
###begin p 5
###xml 191 194 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Barker1">[8]</xref>
###xml 196 199 196 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Brotherton1">[9]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Sabin1">[10]</xref>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Choi1">[11]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Huber1">[12]</xref>
###xml 881 884 881 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Palis1">[7]</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Moore1">[13]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Samokhvalov1">[19]</xref>
###xml 1218 1221 1218 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Barker1">[8]</xref>
###xml 1223 1226 1223 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Brotherton1">[9]</xref>
The first signs of embryonic hematopoiesis is the formation of the blood islands on the yolk sac at embryonic day 7.5 (E7.5) which almost exclusively contain primitive erythroid (EryP) cells [8], [9]. EryP cells are nucleated producing the embryonic form of hemoglobin and this stage of embryonic hematopoiesis is referred to as primitive hematopoiesis. The close association between hematopoietic cells and vascular endothelium in the blood islands led Sabin almost a century ago to postulate a common progenitor cell for these cell types referred to as the hemangioblast [10], and a progenitor cell with hemangioblast properties has recently been identified [11], [12]. Intraembryonic hematopoiesis is established approximately at E10.5, initially in the so-called aorta-gonad-mesonephros (AGM) region and shortly thereafter the fetal liver becomes colonised by progenitor cells [7], [13]-[19], marking the switch from primitive to definitive hematopoiesis as the formation of the whole spectrum of hematopoietic lineages including the definitive erythroid (EryD) lineage commences at this stage. The latter cell type differs from the EryP lineage in that they are smaller, lack nucleus and produce adult hemoglobin [8], [9].
###end p 5
###begin p 6
###xml 469 483 469 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">White Spotting</italic>
###xml 487 488 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Steel</italic>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sl</italic>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Russell1">[14]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Nocka1">[20]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Nocka2">[21]</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Ogawa1">[22]</xref>
###xml 791 798 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Fleischman1">[23]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Miller1">[26]</xref>
###xml 858 866 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 871 878 871 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Russell1">[14]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Ogawa2">[25]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Broxmeyer1">[27]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-McCulloch1">[30]</xref>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Heinrich1">[31]</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pflanz1">[32]</xref>
###xml 1327 1331 1327 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Yoshida1">[33]</xref>
###xml 1333 1337 1333 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Takizawa1">[34]</xref>
###xml 1384 1391 1384 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1396 1404 1396 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1404 1408 1404 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Audet1">[35]</xref>
###xml 1409 1413 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Peters1">[38]</xref>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
Functional analyses of growth factor receptor-ligand interactions have been informative in the understanding of cellular interactions and signalling molecules important for both early hematopoietic development and regulation of stem and progenitor cells. The receptor tyrosine kinase c-kit and its ligand Stem Cell Factor (SCF, also c-kit ligand, Steel factor or mast cell growth factor) are essential for hematopoietic development since mice lacking functional c-kit (White Spotting or W mutants) or SCF (Steel or Sl mutants) die of a severe anemia in utero[14], [20]. The SCF/c-kit interaction plays a critical role in the expansion of definitive hematopoietic cells in the fetal liver [21], [22], and the SCF/c-kit signalling pathway appears to be important for both self-renewal of HSCs in vivo[23]-[26], and differentiation of HSCs and progenitor cells in vitro and in vivo[14], [25], [27]-[30]. Another signal transduction pathway important for the development of the hematopoietic system is mediated by the glycoprotein 130 (gp130), the common receptor and signal transducer for the interleukin-6 (IL-6) family of cytokines. [31], [32]. Although the precise role of gp130 in hematopoietic stem/progenitor cells is not fully understood signalling via gp130 is important in the expansion of fetal definitive hematopoiesis [33], [34], and appears to influence their function both in vivo and in vitro[35]-[38]. Thus, signalling from the c-kit receptor and the gp130 signal transducer play an import role in the development of the hematopoietic system as well as for stem and progenitor cell function, but molecular mechanisms modulating the activities of, and the interplay between these receptors in stem cells remains to be elucidated.
###end p 6
###begin p 7
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Gadue1">[39]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Keller2">[40]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Choi1">[11]</xref>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Huber1">[12]</xref>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Analyses of early mouse development is hampered by the inaccessibility of the early embryo and the limited amount of tissues at these stages. These aspects can be circumvented by using the embryonic stem (ES) cell system since ES cells can be differentiated in vitro into cystic structures called embryoid bodies (EBs), and this process mimic the essential features of the gastrulation process [39]. Similar to the embryo, the first hematopoietic precursor cell population to develop in EBs is a transient wave of the EryP lineage followed by the development of progenitor cells of the various definitive hematopoietic lineages (EryD and myeloid) [40]. Moreover, a progenitor cell population showing hemangioblast characteristics that appears prior to the development of primitive and definitive hematopoietic progenitor cell populations, has been identified in the ES system as well as in the embryo [11], [12]. Thus, the ES/EB system represents a reliable and reproducible model system for analysing the development and regulation of the early embryonic hematopoietic system.
###end p 7
###begin p 8
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Carlsson1">[43]</xref>
###xml 845 853 845 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Laker1">[44]</xref>
We have previously shown that expression of the LIM-homeobox gene Lhx2 (MGI:96785, NM_010710) in hematopoietic progenitor cells derived from ES cells differentiated in vitro can promote self-renewal of a rare SCF-responsive progenitor cells present in EBs [41]. These progenitor cells could be identified in clonal assays and used to establish SCF-dependent multipotential definitive hematopoietic progenitor cell (HPC) lines sharing many basic properties with normal early fetal HSCs [41]-[43]. However, these experiments were carried out by retroviral delivery of the Lhx2 cDNA to the cells and a putative contribution to the observed phenotype by inactivation of tumour suppressor genes or activation of oncogenes caused by retroviral integration has not been excluded. Moreover, expression from retroviral vectors in ES cells differentiated in vitro is very inefficient [41], [44], and therefore it is not possible by using the retroviral system to systematically analyse the effects of Lhx2 expression in the ES/EB system. Thus, expression of Lhx2 can generate HSC-like cell lines but the specificity and efficiency of this event is not known.
###end p 8
###begin p 9
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1A</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Kyba1">[45]</xref>
To further address the role of Lhx2 in during embryonic development of the hematopoietic system, we have introduced Lhx2 cDNA into Ainv15 ES cells where its expression is efficiently regulated by a Tet-on system (Fig. 1A) [45]. Lhx2 expression directly induce self-renewal of a distinct multipotent progenitor cell within EBs in synergy with specific signalling pathways. However, Lhx2 appears to have different and even opposite effects in other cell types as its expression completely blocks proliferation of EryP precursor cells and to some extent also EryD precursor cells, and interferes with the initial steps of ES cell differentiation.
###end p 9
###begin title 10
Generation of ES cell lines with inducible gene expression. A.
###end title 10
###begin p 11
###xml 351 389 351 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hypoxanthine-phosphoribosyltransferase</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26</italic>
###xml 1063 1071 1063 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The iLhx2, iLhx2-GFP and iGFP ES cell lines were generated by co-transfecting Ainv15 ES cells with the plox vector containing the respective gene construct together with a vector containing the Cre recombinase as described in ref. 45. The plox vector will be inserted into the loxp site down stream of the tet-responsive element (TRE) adjacent to the Hypoxanthine-phosphoribosyltransferase (HPRT) gene. The reverse tet transactivator (rTA) is inserted into the ubiquitously expressed ROSA26 locus in the Ainv15 ES cells. B. Lhx2 expression is measured by real-time PCR analysis of iLhx2 ES cells cultured in the absence (-Dox) or presence (+Dox) of dox for 2 days. C. FACS analysis of the iLhx2-GFP ES cells cultured in the absence (-Dox) or presence (+Dox) of dox for two days. D. Lhx2 expression measured by RT-PCR at different time points (in hrs) after dox addition to iLhx2 ES cells. Expression of HPRT was used as an internal control. E. Analysis of EryP precursor cells in day 6 EB when dox is added to the control iGFP ES cells at different stages during in vitro differentiation. F. Analysis of definitive CFCs in day 6 EBs when dox is added to iGFP cells at different stages of ES cell differentiation. - control, no addition of dox, +- addition of dox during ES cell differentiation from day 0 to day 6, -+ addition of dox to the clonal assays of the EB cells, ++ addition of dox to both the ES cell differentiation from day 0 to day 6 and to the clonal assays of the EB cells.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Generation of ES cell lines with inducible Lhx2 expression
###end title 13
###begin p 14
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 439 447 439 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1A</xref>
###xml 758 768 758 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1B, C</xref>
###xml 925 932 925 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1D</xref>
###xml 1058 1066 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1202 1215 1202 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1E and F</xref>
###xml 1374 1382 1374 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A systematic analysis of Lhx2 function in ES cells differentiated in vitro using retroviral vectors is not possible due to the inefficient and unpredictable expression pattern from such vectors in the ES/EB system [41]. Introduction of Lhx2 cDNA into the Ainv15 ES cells would allow for a more thorough analyses of Lhx2 function since it is possible to conditionally regulate Lhx2 expression in ES cells and during ES cell differentiation in vitro. Three different ES cell line were generated and referred to as iLhx2, iLhx2-GFP and iGFP ES cell lines (Fig. 1A). Efficient upregulation of mRNA and protein expression from the different cDNA constructs introduced into the respective ES cell line was achieved by adding doxycyclin (dox) to the culture media (Fig. 1B, C). Maximum Lhx2 expression was obtained within 24 hrs after dox addition and significant Lhx2 expression could be detected already 6 hrs after dox addition (Fig. 1D). Addition of dox to control ES cells (and hence GFP expression) did not interfere with any stage of ES cell differentiation in vitro, neither on hematopoietic commitment during EB formation nor on EryP precursor cells and definitive CFCs in clonal assays of EB cells (Fig. 1E and F). Thus, this ES cell system is amendable for systematic analysis of the specific effect(s) of Lhx2 expression at different time points during differentiation in vitro.
###end p 14
###begin title 15
Lhx2 expression in clonal assays of EB cells inhibit proliferation of EryP precursors and increase the frequency of definitive CFCs
###end title 15
###begin p 16
###xml 99 106 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1D</xref>
###xml 555 565 555 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2A, B</xref>
###xml 763 773 763 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2A, B</xref>
###xml 957 964 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2C</xref>
###xml 1291 1298 1291 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2D</xref>
###xml 1425 1432 1425 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2E</xref>
###xml 1502 1509 1502 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2F</xref>
Since significant expression of Lhx2 occurred almost immediately after dox addition (within 6 hrs, Fig. 1D), we initially wanted to analyse the effect of Lhx2 expression directly on various hematopoietic progenitor cell populations by adding dox to the clonal assays performed on day 6 EB cells. The most obvious effects of turning Lhx2 expression on in clonal assays of EB cells generated from the iLhx2 ES cell lines, were a complete block in proliferation of EryP precursor cells and an approximate 3-fold increase in the frequency of definitive CFCs (Fig. 2A, B). Adding dox to EB cells generated from the iLhx2-GFP ES cell line only partially blocked proliferation of EryP precursor cells and did not significantly increase the frequency of definitive CFCs (Fig. 2A, B). Gene expression analysis showed that the iLhx2-GFP ES cells expressed approximately 50% less Lhx2 compared to the iLhx2 ES cells in the presence of saturating concentration of dox (Fig. 2C). To confirm that the difference in phenotype between iLhx2 and iLhx2-GFP ES cells was solely due to different levels of Lhx2 expression, we replated EB cells generated from the iLhx2 ES cells in clonal assays with different concentrations of dox. The level of Lhx2 expression increased with increasing concentrations of dox (Fig. 2D), and increased expression of Lhx2 expression correlated to the level of inhibition of proliferation of EryP precursor cells (Fig. 2E), and to the synergistic effect on the frequency of definitive CFCs (Fig. 2F). These results show that Lhx2 have different effects on hematopoietic precursors within EBs depending on what cells it is expressed in, and the level of expression is important for these effects.
###end p 16
###begin title 17
Lhx2 expression in clonal assays inhibits proliferation of EryP precursor cells and increase the frequency of definitive CFCs. A.
###end title 17
###begin p 18
Frequency of EryP precursor cells in day 6 EB cells generated from the iLhx2 or iLhx2-GFP ES cell lines if clonal assays were performed in the absence (-Dox) or presence (+Dox) of dox B. Relative frequency of definitive CFCs in day 6 EB cells generated from the iLhx2 or iLhx2-GFP ES cell lines if the clonal assays were performed in the absence (-Dox) or presence (+Dox) of dox. C. Relative expression of Lhx2 analysed by real-time PCR comparing iLhx2 and iLhx2-GFP ES cells cultured in the presence of dox for 2 days. D. Relative Lhx2 expression analysed by real-time PCR in iLhx2 ES cells cultured for 2 days in the presence of dox at the indicated concentrations. Maximal Lhx2 expression is reproducibly achieved in the presence of 2 microg/ml of dox which is arbitrarily set as 1. E. Frequency of EryP precursor cells in clonal assays of day 6 EBs performed in the presence of dox at the indicated concentrations. F. Frequency of definitive CFCs in clonal assays of day 6 EBs performed in the presence of dox at the indicated concentrations. *p<0,01 compared to no dox addition (0 ng/ml). **p<0,02 compared to no dox addition.
###end p 18
###begin title 19
SCF and IL-6 is necessary and sufficient for the synergistic effect on colony formation induced by Lhx2 expression in clonal assays
###end title 19
###begin p 20
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Carlsson1">[43]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo3">[46]</xref>
###xml 479 489 479 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g003">Fig. 3A, B</xref>
###xml 627 634 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g003">Fig. 3A</xref>
###xml 946 953 946 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g003">Fig. 3C</xref>
###xml 1602 1609 1602 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Fig. 2A</xref>
###xml 1744 1748 1744 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 1948 1955 1948 1955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g003">Fig. 3A</xref>
We have previously shown that SCF is essential for the generation and maintenance of HSC-like cell lines when Lhx2 is expressed in hematopoietic cells [41], [43], [46]. We therefore wanted to elucidate whether the synergistic effect was growth factor-specific. The synergistic effect of Lhx2 expression on colony formation was observed in most factor combinations containing SCF whereas the effect was less pronounced or absent if SCF was not included in the factor combination (Fig. 3A, B). No synergistic effect of Lhx2 expression on colony formation was observed in clonal assays when EB cells were replated in SCF and epo (Fig. 3A), suggesting that activation of c-kit signalling is necessary but not sufficient for the synergistic effect of Lhx2 expression on colony formation. The least complex factor combination that consistently showed a pronounced synergistic effect on colony formation when Lhx2 expression was turned on was SCF/IL-6 (Fig. 3C). Thus, simultaneous activation of c-kit and the gp130 signal transducer is necessary and sufficient for the synergistic effect on colony formation exerted by Lhx2 expression. The definitive progenitor cells normally responding to SCF/IL-6/epo generate macrophage colonies and definitive erythroid colonies usually containing megakaryocytes and/or macrophages. Mature definitive erythrocytes assessed as hemoglobinised (red) cells rarely formed in the colonies generated in the presence of dox (data not shown), suggesting that Lhx2 expression also inhibited proliferation of the EryD precursors as was also observed for the EryP precursors cells (Fig. 2A), whereas it appears not to interfere with differentiation into mast cells, megakaryocytes, macrophages and neutrophilic granulocytes [41]. Proliferation of hematopoietic progenitor cells expressing Lhx2 in clonal assays is completely dependent on addition of growth factors since Lhx2 expression by itself did not promote proliferation (Fig. 3A, No factors). Thus, Lhx2 expression synergistically increase the frequency of CFCs in EBs and the combination of SCF/IL-6 is necessary and sufficient for this Lhx2-induced effect.
###end p 20
###begin title 21
The synergistic effect of Lhx2 expression on colony formation is growth factor-specific. A.
###end title 21
###begin p 22
Frequency of definitive CFCs in day 6 EB cells generated from iLhx2 ES cells responding to the indicated growth factors/growth factor combinations in clonal assays performed in the absence (-Dox) or presence (+Dox) of dox. B. Frequency of definitive hematopoietic progenitor cells in day 6 EB cells responding to the indicated growth factor combinations in clonal assays in the absence (-Dox) or presence (+Dox) of dox. Factor mix is Tpo, IL-3, IL-6, Flt3L, epo. C. Number of definitive hematopoietic progenitor cells responding to the indicated growth factor combinations in the absence (-Dox) or presence (+Dox) of dox. * p<0,002, ** p<0,01, *** p<0,005.
###end p 22
###begin title 23
The increase in CFCs induced by Lhx2 expression directly correlates to the efficiency in generating HSC-like cell lines
###end title 23
###begin p 24
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Carlsson1">[43]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo3">[46]</xref>
###xml 1146 1167 1146 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1177 1181 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
###xml 1478 1485 1478 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002025-t001">Table 1</xref>
###xml 1687 1694 1687 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002025-t001">Table 1</xref>
###xml 1913 1920 1913 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002025-t001">Table 1</xref>
###xml 2193 2200 2191 2198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g004">Fig. 4A</xref>
###xml 2455 2462 2453 2460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002025-t001">Table 1</xref>
###xml 2665 2679 2663 2677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g004">Figure 4A to T</xref>
###xml 2883 2885 2881 2883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 2894 2896 2890 2892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 2974 2976 2970 2972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
We have previously shown that Lhx2 expression in hematopoietic progenitor cells derived from ES cells differentiated in vitro and from adult bone marrow could lead to the generation of HSC-like cell lines [41]-[43], [46]. However, since we used retroviral vectors in these experiments we have not been able to exclude the contribution of secondary genetic effects caused by the fortuitous insertion of the retroviral vector into the genome leading to inactivation of tumour suppressor genes or activation of oncogenes. By using the Ainv15 ES cell lines containing the different Lhx2 constructs we could elucidate if Lhx2 expression is necessary and sufficient for generating HSC-like cell lines and the efficiency of this event. To address these issues we analysed the efficiency of establishing HSC-like cell lines from individual colonies randomly picked from the clonal assays of EBs generated from the iLhx2 and iLhx2-GFP ES cell lines (e.g. addition of dox leads to high and intermediate levels of Lhx2 expression, respectively). The generated HSC-like cell lines were denoted dox-dependent hematopoietic progenitor cell (DoxHPC) lines (see Materials and Methods and ref. [47]). The most efficient way of generating DoxHPC lines (60-69% of the picked colonies) was to transfer colonies from the clonal assays containing SCF/IL-6/epo/dox to liquid cultures containing SCF/IL-6/dox, performed on EBs generated from the ES cells expressing the highest level of Lhx2 (iLhx2), (Table 1). A low frequency (3% of picked colonies) of DoxHPC lines was obtained when the same approach was applied to the EBs generated from the ES cell line expressing intermediate levels of Lhx2 (iLhx2-GFP) (Table 1). No DoxHPC lines could be generated when colonies from clonal assays containing SCF/epo/dox of EBs generated from either iLhx2 or iLhx2-GFP ES cell line, were transferred to liquid cultures supplemented with SCF/dox (Table 1). The relative increase in CFCs when dox is added to the clonal assays containing SCF/IL-6/epo performed on the EB cells generated from the iLhx2 ES cells is on average 3,1-fold +/-0,5 (9 independent experiments) as compared to when dox is not added to the clonal assays (Fig. 4A). With a 3,1-fold increase in colony formation, the increase corresponds to 68% of the total number of colony forming cells. This figure is similar to the efficiency in generating DoxHPC lines from individual colonies (60-69%) in equivalent experiments (Table 1), whereas the efficiency in generating DoxHPC lines from individual colonies was low or non-existing where limited or no synergistic effect was observed after dox addition to the clonal assays (compare Figure 4A to Table 1). Thus, the efficiency in generating DoxHPC lines directly correlated to the increase in CFCs in EBs. The frequency of CFCs in day 6 EBs when dox was added to the clonal assay was on average 8,0x10-4+/-1,3x10-4, hence the frequency of the Lhx2-responsive progenitor cells would be 5,44x10-4 (e.g. 68% of the total CFCs) or 1 in 1838 EB cells.
###end p 24
###begin title 25
The efficiency in generating DoxHPC lines directly correlates to the synergistic effect of Lhx2 expression on colony formation, and the generation and maintenance of the DoxHPC lines is optimal in SCF/IL-6. A.
###end title 25
###begin p 26
Summary of the synergistic effect of Lhx2 expression (+Dox) on definitive hematopoietic colony formation of EB cells generated from the iLhx2 ES cells (high level of Lhx2 expression in 2 microg/ml of dox) or iLhx2-GFP ES cells (intermediate level of Lhx2 expression in 2 microg/ml of dox) replated in SCF/IL-6, or EB cells generated from the iLhx2 ES cells replated in SCF alone. * p<0,0001. B. Relative growth of a DoxHPC lines cultured in either IL-6, SCF/IL-6, or SCF. C. Relative expression of IL-6 analysed by real-time PCR comparing a DoxHPC line cultured either in SCF/IL-6 or in SCF for 8 days.
###end p 26
###begin title 27
Efficiency in generating DoxHPC lines from individual colonies in clonal assays of EB cells
###end title 27
###begin p 28
(Number of DoxHPC lines generated/Number of colonies picked)
###end p 28
###begin p 29
ND, Not done.
###end p 29
###begin p 30
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g004">Fig. 4B</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g004">Fig. 4B</xref>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g004">Fig. 4C</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
To analyse if the growth requirements of established DoxHPC lines were stable during culture we cultured them under different conditions. If DoxHPC lines were cultured in IL-6 alone viability rapidly decrease within 24 hrs and no live cells can be recovered after 48 hrs (Fig. 4B). If the DoxHPC lines are cultured in SCF alone the viability slightly decrease but the cells recover after a few days and eventually start to proliferate albeit at a 3-4 times slower rate compared to cells cultured in SCF and IL-6 (Fig. 4B). The recovery of the cells correlated to an upregulation of expression of the endogenous IL-6 gene (Fig. 4C), suggesting that endogenous IL-6 expression can partly compensate for withdrawal of exogenously added IL-6. Moreover, all DoxHPC lines tested thus far rapidly differentiated into various hematopoietic lineages (usually neutrophilic granulocytes, macrophages, megakaryocytes and mast cells) upon dox withdrawal [47], suggesting that Lhx2 expression induced self-renewal of a distinct SCF/IL-6 responsive multipotential progenitor cell population present in EBs and maintenance of this progenitor cell as DoxHPC lines requires continuous c-kit and gp130 signalling.
###end p 30
###begin title 31
Analyses of the effects of Lhx2 expression at different stages of ES cell differentiation
###end title 31
###begin p 32
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Choi1">[11]</xref>
###xml 846 853 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5A</xref>
###xml 1086 1093 1086 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5A</xref>
###xml 1221 1228 1221 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5A</xref>
###xml 1624 1628 1624 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Choi1">[11]</xref>
###xml 1857 1866 1857 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Figure 5B</xref>
###xml 2294 2301 2294 2301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5C</xref>
###xml 2549 2553 2549 2553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
###xml 2839 2846 2839 2846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5C</xref>
Since Lhx2 expression appeared to promote proliferation of a specific multipotential definitive hematopoietic progenitor cell population in the EB we wanted to analyse the development of this progenitor cell during EB formation, and whether Lhx2 expression also could affect pre-hematopoietic mesoderm and/or the hemangioblast population present in the EBs approximately at day 3-4 of differentiation [11]. To start to address these issues we performed clonal assays in the presence or absence of dox on EBs generated from the iLhx2 ES cell line from day 2,5 to day 8 of differentiation. These experiments revealed that the synergistic effect of Lhx2 expression on colony formation was limited to the time points when significant numbers of definitive hematopoietic progenitor cells were detected within EBs starting at day 5 of differentiation (Fig. 5A). The most pronounced synergistic effect on colony formation of Lhx2 expression was obtained at day 6 of differentiation when the highest frequency of progenitor cells normally responding this factor combination was present in EBs (Fig. 5A). After this time point the frequency of this progenitor cell rapidly declined to be undetectable at day 8 of differentiation (Fig. 5A). To analyse the effect of Lhx2 expression on the hemangioblast population that is present during early EB development, we replated day 3.25 EB cells in clonal assays supplemented with SCF and VEGF, a factor combination that promotes proliferation of blast cell colony-forming cell (CFC-Blast) leading to formation of the blast cell colony that contains cells with hemangioblast characteristics [11]. Replating of day 3,25 EBs in this factor combination in the absence or presence of dox showed that Lhx2 expression did not have a synergistic effect, but might instead have a slight negative effect of the CFC-blast population (Figure 5B). To elucidate whether Lhx2 expression affects committed EryP precursors and/or commitment to this lineage from the hemangioblast we added dox to day 3 and 4 EBs, when commitment to this lineage occur, and replated the day 6 EBs without dox when commitment to this lineage has normally occurred. These experiments showed that significant but reduced numbers of EryP precursors are present in day 6 EBs compared to control EBs (Fig. 5C). The reduced number of EryP precursors might be due to residual Lhx2 expression in the clonal assay after dox withdrawal since this precursor appear to be sensitive to Lhx2 expression and it takes at least 24 hrs to decrease expression by 90-95% [47]. To address this issue we added dox at day 3 and withdrew it at day 5 to allow the expression level to decrease significantly before the clonal assay was performed at day 6. In this experiment the frequency of EryP precursor cells in day 6 EBs was almost equal to that of control EBs (Fig. 5C), suggesting that Lhx2 expression blocks proliferation of precursor cells committed to the EryP lineage but does not interfere with the commitment of such precursors from the hemangioblast. These results suggested that Lhx2 expression directly affects the emerging definitive multipotential hematopoietic progenitor cell population whereas it has a limited effect on pre-hematopoietic mesoderm, limited and perhaps even a slight negative effect on the hemangioblast population.
###end p 32
###begin title 33
Analyses of the effect of Lhx2 expression at different stages of ES cell differentiation.
###end title 33
###begin p 34
###xml 697 706 697 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g002">Figure 2A</xref>
###xml 1404 1413 1404 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brachyury</italic>
###xml 1576 1584 1576 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A. Frequency of definitive CFCs in EB cells generated from the iLhx2 ES cells at the indicated days of differentiation starting at day 2,5 analysed in clonal assays in the absence (-Dox) or presence (+Dox) of dox. B. Frequency of CFC-Blast in day 3,25 EBs analysed in clonal assays with SCF and VEGF in the absence (-Dox) or presence (+Dox) of dox. C. Frequency of EryP precursor cells in day 6 EBs if dox is added during the indicated time points of ES cell differentiation and omitted in the clonal assays, compared to when no dox is added (Control) or if dox is added to clonal assays of control EBs (Control +Dox). The latter two control experiments are equivalent to the experiments shown in Figure 2A using the iLhx2 ES cells. D. Relative number EB cells recovered at day 6 of differentiation if dox is added to the iLhx2 ES cell line at the indicated time points during differentiation compared to when EBs are generated in the absence of dox (Control) which is arbitrarily set as 1. * p<0,005 compared to control. ** p<0,01 compared to control. E. Frequency of formation of secondary EBs in clonal assays of day 6 EBs if dox is added at the indicated time points during differentiation. Control EBs are generated without dox. F. Frequency of definitive CFCs in day 6 EBs when dox is added at indicated days of differentiation. Control EBs are generated without dox. G. Relative expression of the Brachyury gene during differentiation of the iLhx2 ES cell line revealing the progression of the gastrulation process in this particular ES cell line during differentiated in vitro.
###end p 34
###begin p 35
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 688 695 688 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5D</xref>
###xml 839 846 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5E</xref>
###xml 1167 1174 1167 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5F</xref>
###xml 1365 1372 1365 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5F</xref>
###xml 1644 1652 1644 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1652 1656 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Keller2">[40]</xref>
###xml 1658 1662 1658 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Wilkinson1">[48]</xref>
###xml 1916 1922 1916 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig 5G</xref>
To further study the effect of Lhx2 expression in ES cells and during ES cell differentiation and gastrulation in vitro we added dox to iLhx2 ES cells at different time points during differentiation and analysed day 6 EBs. Expression of Lhx2 in ES cells cultured in ES cell medium did not significantly affect their ability to self-renew, based on growth rate and viability (data not shown). Expression of Lhx2 during early ES cell commitment, e.g. from 2 days prior to initiation of differentiation (Day -2) and on day 0 and 1 of differentiation until day 6, suppressed EB formation whereas initiation Lhx2 expression after day 2 did not significantly affect the generation of EB cells (Fig. 5D). Moreover, expression of Lhx2 from day 0 and 1 lead to the formation of numerous secondary EBs when day 6 EBs were replated in clonal assays (Fig. 5E), suggesting that suppression of EB formation was most likely due to that Lhx2 expression interfered with the initial commitment step in the differentiation of ES cells. Lhx2 expression from day 0 and 1 also interfered with hematopoietic commitment as almost no hematopoietic progenitor cells were detected in day 6 EB (Fig. 5F), and expression from day 2 slightly affects hematopoietic commitment whereas expression from day 3 instead increase the frequency of definitive hematopoietic progenitor cells in day 6 EBs (Fig. 5F). Expression of the gene Brachyury has been shown to be a marker for formation of nascent mesoderm during primitive streak formation and hence a marker for initiation and progression of the gastrulation process in normal embryos as well as during ES cell differentiation in vitro[40], [48]. Brachyury expression during differentiation of the Ainv15 ES cells is initiated between day 2 and 3 of differentiation and reaches maximum levels at day 4 of differentiation to rapidly decline thereafter to be undetectable at day 6 of differentiation (Fig 5G). These data further support that Lhx2 expression mainly interferes with the initial step in ES cell differentiation leading to the reduction of EB cells as well as hematopoietic mesoderm, whereas it does not interfere with the gastrulation process per se.
###end p 35
###begin title 36
Lhx2 expression in intact EBs transiently induce expansion of definitive hematopoietic progenitor cells without exogenously added growth factors
###end title 36
###begin p 37
###xml 166 172 166 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g003">Fig. 3</xref>
###xml 267 274 267 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5F</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GATA-2</italic>
###xml 903 914 903 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 957 961 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pax6</italic>
###xml 966 970 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Otx2</italic>
###xml 1066 1073 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#946;H1</italic>
###xml 1077 1084 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Beta H1</italic>
###xml 1105 1111 1099 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.5</italic>
###xml 1113 1119 1107 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nfatc1</italic>
###xml 1121 1125 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx1</italic>
###xml 1150 1161 1144 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VE-cadherin</italic>
###xml 1163 1168 1157 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pecam</italic>
###xml 1170 1175 1164 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flk-1</italic>
###xml 1207 1212 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1214 1219 1208 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa2</italic>
###xml 1221 1226 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GATA4</italic>
###xml 1263 1267 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4</italic>
###xml 1269 1273 1263 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rex1</italic>
###xml 1275 1280 1269 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nanog</italic>
###xml 1282 1288 1276 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin</italic>
###xml 1308 1315 1302 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6A</xref>
###xml 1420 1424 1414 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD41</italic>
###xml 1426 1430 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD34</italic>
###xml 1435 1439 1429 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD44</italic>
###xml 1608 1611 1602 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCF</italic>
###xml 1613 1618 1607 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-kit</italic>
###xml 1620 1624 1614 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 1626 1631 1620 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gp130</italic>
###xml 1634 1641 1628 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6A</xref>
###xml 1905 1912 1899 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6B</xref>
###xml 2096 2103 2090 2097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6B</xref>
###xml 2422 2429 2416 2423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6B</xref>
###xml 2770 2777 2764 2771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002025-t001">Table 1</xref>
The Lhx2-induced self-renewal of hematopoietic progenitor cells in clonal assays of EB cells was strictly dependent on specific and exogenously added growth factors (Fig. 3). The increase in CFCs in day 6 EBs when Lhx2 was turned on at day 3 compared to control EBs (Fig. 5F), suggested that Lhx2 expression in intact EBs support self-renewal of hematopoietic progenitor cells independently of exogenously added growth factors. To address this issue and to elucidate if Lhx2 expression in intact EBs would increase the efficiency in generating DoxHPC lines, we added dox at day 3 and 4 of differentiation and analysed day 6 EBs for progenitor cell content and gene expression pattern. Gene expression analysis of day 6 EBs generated from the iLhx2 ES cells when Lhx2 expression was turned on at day 4 showed that genes primarily expressed by definitive hematopoietic cell populations such as GATA-2 and beta-globin (Beta major) and early neuronal ectoderm (Pax6 and Otx2) were significantly upregulated compared to control EBs, whereas genes expressed by EryP cells (betaH1 or Beta H1), cardiac mesoderm (Nkx2.5, Nfatc1, Tbx1), vascular endothelium (VE-cadherin, Pecam, Flk-1), endodermal cell populations (Sox17, Foxa2, GATA4), or various stem cell populations (Oct4, Rex1, Nanog, Nestin) were not changed (Fig. 6A). Other early hematopoietic and/or endothelial-associated genes that Lhx2 expression did not alter were CD41, CD34 and CD44. Moreover, we did not detect any increased expression of the mediators of the c-kit and gp130 signalling pathways when Lhx2 expression was turned on in day 4 EBs (e.g. SCF, c-kit, IL-6, gp130) (Fig. 6A). The increased expression of genes associated with definitive hematopoiesis was confirmed by that the progenitor cells responding to SCF/IL6/epo had increased 5-8-fold within the intact EB when Lhx2 was expressed during this time period compared to control EBs (Fig. 6B). Furthermore, the synergistic effect on colony formation of Lhx2 expression was also observed in the clonal assays of the day 6 EBs when Lhx2 expression was induced from day 3 or 4 (Fig. 6B), indicating both self-renewal and differentiation of the distinct progenitor cell expanded by Lhx2 expression in EBs. Lhx2 expression between day 3 and 5 of differentiation lead to an equivalent expansion of progenitor cells in the EB suggesting that most of the expansion occurs between days 3-5 of differentiation (Fig. 6B). Although expression of Lhx2 in intact EBs from day 4 of differentiation increase the frequency of hematopoietic progenitors in day 6 EBs, it does not to increase the efficiency in generating DoxHPC lines from the clonal assays of day 6 EBs (65% of the picked colonies compared to 69% and 60% when dox was added only to the clonal assays, Table 1). Thus, Lhx2 expression in intact EBs leads to both self-renewal and differentiation of this distinct progenitor cell population.
###end p 37
###begin title 38
Lhx2 expression in intact EBs transiently induce expansion of definitive hematopoietic progenitor cells in the absence of exogenously added growth factors.
###end title 38
###begin p 39
A. Gene expression analysis by real-time PCR on day 6 EB generated from the iLhx2 ES cells comparing control EBs (-Dox) to those where Lhx2 expression was turned on at day 4 of differentiation (+Dox). B. Frequency of definitive CFCs responding to SCF/IL-6/epo in clonal assays of day 6 EBs in the presence (+Dox) or absence (-Dox) of dox, if dox was added at day 3 or 4 of differentiation, or if dox was present between day 3 and 5 of differentiation. Control is day 6 EBs generated without dox. C. Frequency of definitive CFCs responding to SCF/IL-6/epo in clonal assays of day 6, 7 and 8 EBs in the presence (-Dox) of absence (+Dox) of dox if dox was added or not at day 4 of differentiation. Hence, the following combinations were analysed: -- no dox added to the ES cells differentiation or to clonal assays of EB cells, -+ dox was added to clonal assays of day 6, 7 and 8 EB cells. +- dox was added to day 4 EB and no dox was added to clonal assays of the day 6, 7 and 8 EB cells. ++ dox was added to day 4 EBs and to the clonal assays of the day 6, 7 and 8 EB cells. Asterisks indicate where the difference in CFC between clonal assays performed in the absence or presence of dox is statistically significant, *p<0,005, **p<0,05.
###end p 39
###begin p 40
###xml 176 183 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g005">Fig. 5A</xref>
###xml 596 603 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6C</xref>
During normal EB development in the absence of exogenously added growth factors the frequency of hematopoietic progenitor cells rapidly decline after day 6 of differentiation (Fig. 5A). To elucidate if Lhx2 expression in intact EBs promote expansion of hematopoietic progenitor cells to later stages when they are normally exhausted, we also analysed progenitor cell content in day 7 and 8 EBs when Lhx2 expression was turned on at day 4. This experiment revealed that Lhx2 expression maintained significant numbers of progenitor cells until day 8 EBs when they are exhausted in the control EBs (Fig. 6C). The synergistic effect of Lhx2 expression in the clonal assays of day 7 and 8 EBs was not significant as in the clonal assays of day 6 EBs, further supporting the notion that Lhx2 expression can only induced self-renewal of this distinct hematopoietic progenitor cell for a limited time in intact EBs. Thus, Lhx2 expression in intact EBs induce self-renewal the specific hematopoietic progenitor cell independently of exogenously added growth factors for a limited time (day 3-5) during EB development.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 167 176 167 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g007">Figure 7:</xref>
###xml 511 519 511 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1472 1476 1472 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 1478 1482 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
###xml 1665 1666 1665 1666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1676 1680 1676 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 1883 1884 1883 1884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1923 1927 1923 1927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Keller2">[40]</xref>
###xml 2164 2168 2164 2168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2</italic>
###xml 2229 2234 2229 2234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hox11</italic>
###xml 2236 2241 2236 2241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxb4</italic>
###xml 2243 2247 2243 2247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx4</italic>
###xml 2249 2254 2249 2254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad1</italic>
###xml 2256 2261 2256 2261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 2263 2269 2263 2269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mMixl1</italic>
###xml 2279 2286 2279 2286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</italic>
###xml 2296 2300 2296 2300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Kyba1">[45]</xref>
###xml 2302 2306 2302 2306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Helgason1">[49]</xref>
###xml 2307 2311 2307 2311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Willey1">[57]</xref>
By using an efficient system to express Lhx2 during ES cell differentiation in vitro we have shown that Lhx2 expression cause three different phenotypes summarised in Figure 7: 1) self-renewal of a distinct definitive multipotential hematopoietic progenitor cell in EBs in a growth factor-specific manner, 2) complete block in proliferation and differentiation of committed EryP precursor cells and to some extent also EryD precursor cells, and 3) interference with the initial steps in ES cell differentiation in vitro. The effect of Lhx2 on hematopoietic progenitor cells is most likely due to a direct effect on the emerging definitive multipotential progenitor cells in the EBs and not due to an indirect effect by increasing hematopoietic commitment from pre-hematopoietic mesoderm, or by promoting proliferation of the hemangioblast cell population. The lack of effect of Lhx2 expression in clonal assays of day 3 and 4 EBs when the hemangioblast is the dominating progenitor cell population with hematopoietic potential, whereas expression in intact EBs from day 3 and 4 to day 6 of differentiation expand definitive hematopoietic progenitor cells, would suggest that Lhx2 expression does not induce self-renewal until the hemangioblast cell has matured into a progenitor cell harbouring only definitive hematopoietic potential. Moreover, non of the cell lines tested that we have generated from ES cells previously have shown any primitive hematopoietic potential [41], [47], further supporting this assumption. The frequency of the Lhx2-responsive progenitor cell within day 6 EBs in our previous work using retroviral vectors was usually less than 1 in 104 EB cells [41], whereas in this study we can show that the frequency of the Lhx2-responsive progenitor cell is 1 in 1838 EB cells. This frequency corresponds to 1-2 cells per EB since each EB contain on average 2-3x103 cells after 6 days of differentiation [40], whereas in our previous work the frequency corresponds to less than 1 progenitor per 3-4 EBs. This efficient and growth factor-specific induction of self-renewal of a specific multipotential progenitor cell present in EBs is unique to Lhx2 as compared to other genes tested in the ES system, such as Hox11, Hoxb4, Cdx4, Smad1, Stat5, mMixl1, and the BCR/ABL oncogene [45], [49]-[57].
###end p 42
###begin title 43
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
An overview of the effects of Lhx2 expression during ES cell differentiation in vitro.
###end title 43
###begin p 44
###xml 398 406 398 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
1) Lhx2 expression and simultaneous activation of the c-kit receptor tyrosine kinase and gp130 signal transducer via IL-6 directly induce self-renewal of a distinct multipotential definitive hematopoietic progenitor cell (Def. HPC) present in the EB (1a) leading to the generation of HSC-like cell lines (DoxHPC lines) strictly dependent on Lhx2 expression and SCF/IL-6 for continuous self-renewal in vitro (1b). 2) Lhx2 expression inhibits proliferation of committed primitive erythroid (EryP) precursor cells (2a) and definitive erythroid (EryD) precursor cells (2b). 3) Lhx2 expression interferes with the initial step in ES cell differentiation whereas it does not interfere with the gastrulation process. Mast, mast cells. Mac, macrophages. Neut, neutrophilic granulocyte. Meg, megakaryocytes.
###end p 44
###begin p 45
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Heinrich1">[31]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pflanz1">[32]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Yoshida2">[58]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Sui1">[59]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Sui3">[61]</xref>
###xml 1238 1242 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-VarnumFinney1">[62]</xref>
###xml 1244 1248 1241 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Baba1">[63]</xref>
###xml 1713 1714 1710 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1741 1742 1738 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1771 1775 1768 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
###xml 2088 2092 2085 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Porter1">[64]</xref>
###xml 2093 2097 2090 2094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Rhee1">[68]</xref>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 877 882 <span type="species:ncbi:9606">human</span>
###xml 1478 1483 <span type="species:ncbi:9606">human</span>
Signalling via the c-kit receptor and the gp130 signal transducer by IL-6 appear to be necessary and sufficient to promote Lhx2-induced self-renewal of multipotential hematopoietic progenitor cells in the ES/EB system. The growth factors that signal via gp130, IL-6, IL-11, LIF (leukemia inhibitory factor), CNTF (ciliary neurotrophic factor), OSM (oncostatin M), CT-1 (cardiotrophin-1), CLC (cardiotrophin-like cytokine) and IL-27, affect a plethora of different cell types [31], [32], and it has been shown that direct activation of gp130 does not require the specific ligand for cell type-specific signalling [58]. Interestingly, signalling via c-kit and direct activation of gp130 is also a potent regulator of human hematopoietic progenitor/stem cells further supporting the idea that modulation of these pathways profoundly influences stem cell function also in cells of human origin [59]-[61]. Moreover, c-kit receptor signalling together with gp130 signalling by IL-6 have previously been shown to be involved in the maintenance of immortalised HSC-like cell lines after transduction of HSCs with a constitutively active Notch1 receptor, or a constitutively active beta-catenin that activates the canonical Wnt signalling pathway [62], [63], although the specificity or efficiency of these events are unknown. These observations suggest that c-kit signalling together with gp130 signalling are potent regulators of hematopoietic stem/progenitor cells including those of human origin, and we have shown that Lhx2 expression efficiently modulate the interplay between these receptors. To elucidate the function of Lhx2 in stem/progenitor cells we have done global gene expression analyses comparing the Lhx2+ DoxHPC lines to their Lhx2- progeny upon dox withdrawal [47], and started to address the contribution of different signalling pathways identified in this screen. Based on the function of Lhx2 in stem/progenitor cell populations in various organ systems such as olfactory epithelium, forebrain ventricular zone, hair follicles, and the progress zone during limb development [64]-[68], elucidation of Lhx2 function would give insights into progenitor/stem cell physiology also in non-hematopoietic organs.
###end p 45
###begin p 46
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Kustikova1">[69]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo1">[41]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo3">[46]</xref>
The generation of HSC-like cell lines in our previous work was a relatively rare event and we could not exclude the influence from secondary genetic effects due to retroviral integration, which has been shown to be a non-random event causing a proliferative advantage of the transduced clone [69]. Our inability to generate DoxHPC lines in SCF alone suggests that retroviral insertion might contribute to the generation of HSC-like cell lines in SCF alone in our previous work [41], [46]. Upregulation of endogenous IL-6 gene expression upon IL-6 withdrawal from DoxHPC lines suggests that endogenous IL-6 expression could further contribute to Lhx2 induced self-renewal in SCF alone. However, the results obtained herein exclude the influence of retroviral insertion in the generation of HSC-like cell lines and strongly suggest that induction of self-renewal of the multipotential progenitor cell is a direct and specific effect of Lhx2 expression together with c-kit and gp130 signalling.
###end p 46
###begin p 47
###xml 436 444 436 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Keller2">[40]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Schmitt1">[70]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-McClanahan1">[71]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Schmitt1">[70]</xref>
###xml 634 641 634 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g006">Fig. 6A</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 836 843 836 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2<sup>&#8722;/&#8722;</sup></italic>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo2">[42]</xref>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Porter1">[64]</xref>
###xml 1127 1131 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Porter1">[64]</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Wandzioch1">[72]</xref>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
In contrast to the strict dependence on exogenously added growth factors for Lhx2-induced self-renewal of cells in clonal assays, Lhx2 expression in intact EBs transiently induce self-renewal of these progenitor cells independent of exogenously added growth factors. This observation suggests that the EB environment can provide the growth factors required for Lhx2-induced self-renewal. SCF is expressed during ES cell differentiation in vitro[40], [70], [71], whereas IL-6 is not expressed during the early stages of EB development [70], and we have not seen any evidence for that Lhx2 expression in EBs upregulate IL-6 expression (Fig. 6A). We have previously shown that the HSC-like cell lines expressing Lhx2 self-renew by a cell nonautonomous mechanism which is in agreement with the cell nonautonomous hematopoietic phenotype in Lhx2-/- mice [42], [64]. Since Lhx2 is normally expressed in a mesenchymal cell population (hepatic stellate cells) in the fetal liver and these cells are important for the differentiation, organization and expansion of all cell types in the liver including those of the hematopoietic niche [64], [72], it would suggest that Lhx2 regulates genes in mesenchymal cells encoding mediators involved in cell-to-cell interactions. Lhx2 expression in mesenchymal cells in addition to expression in hematopoietic cells might therefore enhance the effect on hematopoietic cells in intact EBs and the transient nature of the expansion (day 3-5 of EB development) suggests that such interactions are only possible during early EB development. Elucidation of the molecular basis for Lhx2-induced self-renewal might therefore give insights into both cell autonomous and cell nonautonomous mechanisms regulating normal HSCs function.
###end p 47
###begin p 48
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo3">[46]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter2">[73]</xref>
###xml 1011 1015 1011 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2</italic>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-ValgeArcher1">[74]</xref>
###xml 1247 1251 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Visvader1">[76]</xref>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Another obvious effect of Lhx2 expression on hematopoietic precursors was the complete block in proliferation of committed EryP precursor cells and to some extent also of EryD precursor cells. This observation could explain the large fluctuation in erythropoiesis in vivo seen in stem cell-deficient mice engrafted with adult HSC-like cell lines expressing Lhx2, whereas generation of myeloid cells appeared to be relatively unaffected [46]. Since the level of Lhx2 expression is critical for the inhibition of erythroid development, these fluctuations could simply reflect fluctuations in the level of Lhx2 expression in erythroid precursors, and hence when Lhx2 expression is below a critical threshold the erythroid precursor can escape the inhibition. We also noticed a significantly decreased mean corpuscular hemoglobin concentration (MCHC) in erythrocytes originating from the HSC-like cell lines in the engrafted animals [73], suggesting that Lhx2 expression could interfere with globin expression. The Lhx2 gene encodes a LIM-domain-containing transcription factor and transcriptional regulators containing LIM-domains (Lmo2) and LIM-domain-interacting domains (Ldb1) are known to be critically involved in erythroid differentiation [74]-[76]. Since Lhx2 is not normally expressed in hematopoietic cells, the LIM-domain of the Lhx2 protein might physically interfere with these protein interactions and depending on the amount of Lhx2 protein in the cell cause dominant negative effects leading to the block in erythroid development and/or altered globin expression.
###end p 48
###begin p 49
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lhx2</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Lee1">[77]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Boyer1">[78]</xref>
It has been suggested that expression of the Lhx2 gene is repressed in ES cells by the Polycomb complex [77], [78], implying that Lhx2 would promote differentiation of ES cells. However, our data reveal that Lhx2 expression does not have any obvious effects on the self-renewal of ES cells but it does interfere with the early steps in ES cell differentiation leading to reduced number of EB cells and suppression of hematopoietic mesoderm. These effects are only seen if Lhx2 is turned very early during ES cell differentiation (primarily from day 0 and 1) whereas expression after day 2 has subtle effects on the differentiation. Since our differentiation protocol is prone towards mesodermal commitment and is inefficient in promoting ectodermal and endodermal commitment, our results can be interpreted in at least two different ways. Firstly, Lhx2 interferes with conversion of primitive ectoderm to more differentiated tissues. Secondly, Lhx2 expression promotes differentiation towards a lineage that is not supported by our differentiation protocol. One of the first cell types expressing Lhx2 in the developing embryo is the neuronal ectoderm of the prospective forebrain prior to E9 (unpublished observation) and gene expression analysis of the day 6 EBs when Lhx2 was turned on at day 4 revealed a significant upregulation of the forebrain markers Pax6 and Otx2. These results suggest that Lhx2 might promote neuronal differentiation which is not supported by our differentiation protocol and neuronal commitment might be more efficient if Lhx2 is turned very early during ES cell differentiation and hence cause the reduced formation of EB cell and suppression of mesodermal commitment. Which of these alternatives that are correct are presently under investigation. Collectively these results show that the effects of Lhx2 expression have striking lineage specificity and that the level of expression is important for these effects. This work provides the first attempt to understand the wide array of functions that Lhx2 have in different organs during embryonic development such as the hematopoietic system, the liver, forebrain and neuronal retina.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Generation of ES cells with inducible gene expression
###end title 51
###begin p 52
###xml 232 234 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Kyba1">[45]</xref>
###xml 701 739 701 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hypoxanthine-phosphoribosyltransferase</italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 817 824 817 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1A</xref>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neo</italic>
###xml 961 968 961 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002025-g001">Fig. 1A</xref>
###xml 1078 1079 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 186 190 <span type="species:ncbi:9913">calf</span>
The Ainv15 ES cell line was maintained on irradiated mouse embryonic feeder (MEF) cells in Dulbeccos modified Eagle medium (DMEM) (Gibco-BRL, United Kingdom) supplemented with 15% fetal calf serum (FCS) (Boehringer, Germany), 1.5x10-4 M monothioglycerol (MTG) (Sigma, Germany) and LIF (Chemicon, Ca, USA). Green fluorescent protein (GFP) cDNA, Lhx2 cDNA or Lhx2 cDNA linked to a GFP cDNA preceded by an internal ribosomal entry site (Lhx2-GFP), was inserted into the plox vector and transfected into the Ainv15 ES cells together with Cre recombinase cDNA as previously described [45]. The plox vector will be inserted into the loxp site down stream of the tet-responsive element (TRE) adjacent to the Hypoxanthine-phosphoribosyltransferase (HPRT) gene by recombination between the chromosomal and plasmid loxp sites (Fig. 1A). Reconstitution of a functional Neo gene by the promoter-ATG sequence (PGK-ATG) allows for selection of successful integration events (Fig. 1A), and hence transfected ES cells were subsequently cultured in 200 microg/ml G418 (Gibco-BRL). Clones of G418R ES cells transfected with the respective gene construct were isolated, pooled and expanded. The resulting cell lines are referred to as iGFP, iLhx2 and iLhx2-GFP ES cell lines, respectively. Induction of gene expression was carried out by adding dox to a final concentration of 2 microg/ml of dox if not stated otherwise. Induction of Lhx2 expression was done using the iLhx2 ES cell line if not stated otherwise.
###end p 52
###begin title 53
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Differentiation of ES cell in vitro
###end title 53
###begin p 54
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Ying1">[79]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Ying2">[80]</xref>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 629 630 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 763 765 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 255 258 <span type="species:ncbi:9685">Cat</span>
###xml 377 380 <span type="species:ncbi:9685">Cat</span>
The iGFP, iLhx2 and iLhx2-GFP ES cell lines used for in vitro differentiation were made feeder-independent in serum-free medium as previously described [79], [80]. Briefly, ES cells cultured on MEF cells were treated with Acutase (Chemicon International, Cat. No. SF006), transferred to gelatinized culture flasks in ESGRO Complete Clonal grade medium (Chemicon International, Cat. No. SF001) and passaged in this medium until no MEFs were present and were subsequently maintained in this medium by 1:4 to 1:5 splits. For differentiation, ES cells were treated with Acutase , washed and transferred at various densities (103-8x103 cells/ml) into Iscoves modified Dulbeccos media (IMDM) (Gibco-BRL) supplemented with 15% FCS (Integro Inc., The Netherlands), 4.5x10-4 M MTG, 5% Protein Free Hybridoma Medium II (PFHMII, GIBCO) and 25 microg/ml ascorbic acid (Sigma). EBs were collected after different days of differentiation, resuspended in Acutase and incubated for three minutes. Two ml of FCS was added and the cells were gently passaged through a syringe with a 20-gauge needle. Ten ml of IMDM supplemented with MTG was added; the cells were spun down and resuspended in fresh IMDM medium supplemented with MTG and 5% FCS.
###end p 54
###begin title 55
Clonal progenitor cell assays of EB cells
###end title 55
###begin p 56
###xml 597 601 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Karasuyama1">[81]</xref>
###xml 783 784 779 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 792 793 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 424 429 <span type="species:ncbi:10090">mouse</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
The clonal assays were carried out in IMDM containing 1% methylcellulose (Fluka, Switzerland) and supplemented with L-glutamine, 300 microg/ml iron-saturated transferrin (Boehringer), 5% PFHMII, 10% plasma-derived serum (Antech Inc., Tx, USA), with or without doxycyclin (dox) (Sigma) and with the indicated growth factors. Growth factors used were: mouse SCF (R&DSystems) at 100 ng/ml, human IL-6 (R&DSystems) at 10 ng/ml, mouse thrombopoietin (tpo) (R&DSystems) at 20 ng/ml, mouse Flt3L (R&DSystems) at 20 ng/ml, IL-3 at 1% of conditioned media from a cell line transfected with mouse IL-3 cDNA [81] and human erythropoietin (epo) (Eprex Janssen-Cilag, Sweden) at 4 IU/ml. EB cells were plated in triplicates in a final volume of 1.25 ml in 35-mm Petri dishes (Falcon 1008) at 7x104 to 2x105 cells/dish. The frequency of EryP precursor cells was determined by scoring the number of EryP colonies after 5 days of incubation and the frequency of definitive colony-forming cells (CFCs) was determined by scoring the number of definitive hematopoietic colonies after 9-10 days of incubation.
###end p 56
###begin title 57
Generation and maintenance of DoxHPC lines
###end title 57
###begin p 58
###xml 324 326 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 951 952 951 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 961 962 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1062 1066 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo2">[42]</xref>
###xml 1068 1072 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Pintodo3">[46]</xref>
###xml 1467 1471 1467 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002025-Richter1">[47]</xref>
Clonal assays containing either SCF/IL-6/epo/dox or SCF/epo/dox were performed on day 6 EBs generated from the iLhx2 and iLhx2-GFP ES cell lines. Individual colonies were randomly picked from the clonal assays after 9-10 days of incubation, transferred to 96-well plates and expanded in IMDM supplemented with 5% FCS, 1.5x10-4 M MTG, and SCF/IL-6/dox or SCF/dox. The individual colonies were cultured for at least 3 weeks after which the cells were analysed for cell morphology by May-Grunwald Giemsa staining of cytospun cells, and at this stage the cultures contained cells either with mast cell morphology or blast cell-like morphology (ref. 47 and data not shown). All cultures containing cells with blast cell-like morphology at this time point generated stable cell lines and are referred to as dox-dependent hematopoietic progenitor cell (DoxHPC) lines. The DoxHPC lines were subsequently maintained in this media at cell densities between 5x105 and 2x106 cells/ml as previously described for other Lhx2-induced HSC-like cell lines (HPC and BM-HPC lines) [42], [46]. The cultures containing cells with mast cell morphology remained as such despite maintained Lhx2 expression. The DoxHPC lines down regulated Lhx2 expression by >95% within 24 hrs after dox withdrawal and all DoxHPC lines tested thus far are multipotential as they differentiate into various myeloid cells (megakaryocyte, macrophages, neutrophilic granulocytes, mast cells) upon dox withdrawal [47]. No cell line could be established from EBs generated from the control iGFP ES cell line in the presence of dox, or from EBs generated from the iLhx2 ES cell line in the absence of dox, as such cells differentiated into mast cells under these culture conditions.
###end p 58
###begin title 59
Gene expression analysis
###end title 59
###begin p 60
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbp</italic>
###xml 665 685 665 685 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGTGTTCCTACCCCCAATGT</named-content>
###xml 709 733 709 733 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGTCATCATACTTGGCAGGTTTCT</named-content>
###xml 741 763 741 763 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAATTGTACCGCAGCTTCAAAA</named-content>
###xml 770 795 770 795 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGTGCAATGGTCTTTAGGTCAAGTT</named-content>
###xml 804 826 804 826 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTGGGCACCACTGGTTATTTC</named-content>
###xml 833 854 833 854 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGTCTTCACCCAGCCTTTCTC</named-content>
###xml 863 883 863 883 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTCCGGCTCACAGCTACTG</named-content>
###xml 890 913 890 913 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATCATTGGCTGCTTCAATCTTCA</named-content>
###xml 923 940 923 940 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGCACGGGCCACTACCT</named-content>
###xml 947 970 947 970 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCGTCTGACAATTTGCACAACAG</named-content>
###xml 981 1003 978 1000 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGCAGCTATCACAAGCATCTG</named-content>
###xml 1010 1037 1007 1034 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AACTTGTCAAAGAATCTCTGAGTCCAT</named-content>
###xml 1052 1074 1046 1068 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTGAGCTCCACTGTGACAAGCT</named-content>
###xml 1081 1104 1075 1098 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGTGGCCCAGCACAATCACGATC</named-content>
###xml 1113 1135 1107 1129 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACTGCAGTGATTGCCATGTTCT</named-content>
###xml 1142 1160 1136 1154 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCATTGGCCCGCTTAACG</named-content>
###xml 1168 1193 1162 1187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAAACGCACCGAAGAATATAAAAG</named-content>
###xml 1200 1222 1194 1216 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCTAGTTTCTGGCCTCTTCGGA</named-content>
###xml 1232 1249 1226 1243 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CACTCGCACGGGCACAT</named-content>
###xml 1256 1281 1250 1275 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAGTTTGGCAGGATCTCTAACAAAC</named-content>
###xml 1290 1312 1284 1306 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCCGAATTAGCTGGACACTCAA</named-content>
###xml 1319 1344 1313 1338 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCTCCTCATAGGACCAGAAGTTGTG</named-content>
###xml 1353 1378 1347 1372 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACAAGTCGGAGGCTTAATTACACAT</named-content>
###xml 1385 1407 1379 1401 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AATCAGAATTGCCATTGCACAA</named-content>
###xml 1417 1436 1411 1430 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCTGGGCGTCTTGTTCTG</named-content>
###xml 1443 1468 1437 1462 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATATGACTCTTGGAAGGATCAGGAA</named-content>
###xml 1477 1502 1471 1496 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGATGGACTTCAACTACAGCTTCTC</named-content>
###xml 1509 1530 1503 1524 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCTGGTGCAGGCTACATGACT</named-content>
###xml 1539 1561 1533 1555 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAGCTCAGTCGCCACCTCTACT</named-content>
###xml 1568 1589 1562 1583 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCGCATTGGACGTTAGAAAAG</named-content>
###xml 1598 1615 1592 1609 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCACCCATGCCCAGCTT</named-content>
###xml 1622 1646 1616 1640 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AACTGACACTCCAGGTGAAATGAG</named-content>
###xml 1655 1674 1649 1668 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGAGCC&gt;GTCTTTCCACCA</named-content>
###xml 1681 1699 1675 1693 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TACCTCCCTTGCCTTGGC</named-content>
###xml 1709 1734 1703 1728 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CACCCCAATCTCGTAGATATGTTTG</named-content>
###xml 1741 1762 1735 1756 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGTAGTGTCCCGTCCCATCTC</named-content>
###xml 1773 1791 1767 1785 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGCGCAGCATCGGGTACT</named-content>
###xml 1798 1825 1792 1819 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTTATAGATGTTTCCCTGCTTGGTTAT</named-content>
###xml 1835 1852 1829 1846 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTGCAGGCATCGGCAAA</named-content>
###xml 1859 1878 1853 1872 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCATTTCGCACACCTGGAT</named-content>
###xml 1889 1910 1883 1904 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCAAGTGCTCTCCTGCTTTCC</named-content>
###xml 1917 1935 1911 1929 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCATCCGTCTCGGCTTT</named-content>
###xml 1946 1966 1940 1960 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCATACGAGCTTCGGATCGA</named-content>
###xml 1973 1996 1967 1990 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGTAACCGTGTAGCTGCACAATG</named-content>
###xml 2005 2029 1999 2023 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGTTTGGACACATTATCCTGAACT</named-content>
###xml 2036 2058 2030 2052 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGAACCGAACCCATTATTTTCG</named-content>
###xml 2069 2091 2063 2085 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCTTCCCCCTTGCCTAATACC</named-content>
###xml 2098 2122 2092 2116 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTTAGGATAGGGAGCCTCAGACAT</named-content>
###xml 2132 2154 2126 2148 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGCCAGCGAGTTAAAGTATGCT</named-content>
###xml 2161 2180 2155 2174 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCGGGCTCCGCGTAGTAG</named-content>
###xml 2190 2213 2184 2207 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCCAACACTCCTCCCAAAGTATC</named-content>
###xml 2220 2243 2214 2237 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTCCCTGTCTTGGTTGATTTCTC</named-content>
###xml 2252 2272 2246 2266 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCACTGTGCTGCCTCCAAGT</named-content>
###xml 2279 2297 2273 2291 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGGCACTGATCCGCAAAC</named-content>
###xml 2307 2331 2301 2325 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAACCAGTGGTTGAAGACTAGCAA</named-content>
###xml 2338 2359 2332 2353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCAATGGATGCTGGGATACT</named-content>
Total RNA was extracted from cell pellets with RNeasy Plus Mini Kit (Qiagen). cDNA was synthesized using the First-strand cDNA synthesis Kit (Amersham Biosciences). Real-time PCR reactions were carried out in triplicates using SYBR green PCR master mix (Applied Biosystems Ca. US) and PCR products were detected with an ABI prism 7000 instrument (Applied Biosystems). The expression levels of the genes tested were normalized to the expression levels of house keeping gene Gapdh (Glyceraldehyde-3-phosphate dehydrogenase) and confirmed with one additional house keeping gene Tbp (TATA box binding protein). The following primers were used: Gapdh forward primer (F) CGTGTTCCTACCCCCAATGT and reverse primer (R) TGTCATCATACTTGGCAGGTTTCT, Tbp F GAATTGTACCGCAGCTTCAAAA and R AGTGCAATGGTCTTTAGGTCAAGTT, CD34 F CTTGGGCACCACTGGTTATTTC and R GGTCTTCACCCAGCCTTTCTC, CD41 F GCTCCGGCTCACAGCTACTG and R ATCATTGGCTGCTTCAATCTTCA, Gata2 F GGCACGGGCCACTACCT and R TCGTCTGACAATTTGCACAACAG, betaH1 F AGGCAGCTATCACAAGCATCTG and R AACTTGTCAAAGAATCTCTGAGTCCAT, beta major F GTGAGCTCCACTGTGACAAGCT and R GGTGGCCCAGCACAATCACGATC, Flk1 F ACTGCAGTGATTGCCATGTTCT and R TCATTGGCCCGCTTAACG, SCF F GAAAACGCACCGAAGAATATAAAAG and R TCTAGTTTCTGGCCTCTTCGGA, c-kit F CACTCGCACGGGCACAT and R AAGTTTGGCAGGATCTCTAACAAAC, CD44 F TCCGAATTAGCTGGACACTCAA and R TCTCCTCATAGGACCAGAAGTTGTG, IL-6 F ACAAGTCGGAGGCTTAATTACACAT and R AATCAGAATTGCCATTGCACAA, gp130 F TGCTGGGCGTCTTGTTCTG and R ATATGACTCTTGGAAGGATCAGGAA, epoR F GGATGGACTTCAACTACAGCTTCTC and R CCTGGTGCAGGCTACATGACT, Otx2 F GAGCTCAGTCGCCACCTCTACT and R CCGCATTGGACGTTAGAAAAG, Pax6 F CCACCCATGCCCAGCTT and R AACTGACACTCCAGGTGAAATGAG, Oct4 F TGAGCC>GTCTTTCCACCA and R TACCTCCCTTGCCTTGGC, GATA4 F CACCCCAATCTCGTAGATATGTTTG and R GGTAGTGTCCCGTCCCATCTC, VE-Cad F AGCGCAGCATCGGGTACT and R GTTATAGATGTTTCCCTGCTTGGTTAT, Pecam F CTGCAGGCATCGGCAAA and R GCATTTCGCACACCTGGAT, Nkx2.5 F CCAAGTGCTCTCCTGCTTTCC and R GCCATCCGTCTCGGCTTT, Nfatc1 F CCATACGAGCTTCGGATCGA and R AGTAACCGTGTAGCTGCACAATG, Tbx5 F CGTTTGGACACATTATCCTGAACT and R TGAACCGAACCCATTATTTTCG, Nestin F CTCTTCCCCCTTGCCTAATACC and R TTTAGGATAGGGAGCCTCAGACAT, Foxa2 F GGCCAGCGAGTTAAAGTATGCT and R CTCGGGCTCCGCGTAGTAG, Sox17 F CCCAACACTCCTCCCAAAGTATC and R TTCCCTGTCTTGGTTGATTTCTC, Rex1 F TCACTGTGCTGCCTCCAAGT and R GGGCACTGATCCGCAAAC, Nanog F AAACCAGTGGTTGAAGACTAGCAA and R TGCAATGGATGCTGGGATACT.
###end p 60
###begin p 61
###xml 308 329 304 325 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAAAGACAAAGCGCATGCGGC</named-content>
###xml 336 357 332 353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGGCACAGAAGTTAAGACTG</named-content>
###xml 366 386 362 382 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CACAGGACTAGAACACCTGC</named-content>
###xml 393 412 389 408 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTGGTGAAAAGGACCTCT</named-content>
Reverse transcriptase (RT) PCR was performed using Taq polymerase (Amplicon, Denmark) on cDNA prepared from feeder-independent iLhx2 ES cells cultured without dox (0 hrs) and in 2 microg/ml of dox for 6, 12, 18 and 24 hours. The samples were loaded on the 1% Agarose gel and the PCR primers used were Lhx2 F AAAAGACAAAGCGCATGCGGC and R CAGGCACAGAAGTTAAGACTG, Hprt F CACAGGACTAGAACACCTGC and R GCTGGTGAAAAGGACCTCT.
###end p 61
###begin p 62
GFP expression analysis was carried in a FACSCaliburtrade mark (Becton Dickinson, Ca USA) using CellQuestPro measuring fluorescence in the FL1 channel on the feeder-independent iLhx2-GFP ES cells cultured as described previously in the presence or absence of 2 microg/ml of dox for 2 days.
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
Data are presented as mean+/-standard deviation (SD). p values were calculated using Student's t test and p values <0,05 were considered as statistically significant.
###end p 64
###begin p 65
We would like to thank Dr. Andrew Elefanty for valuable comments on the manuscript.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells.
###end article-title 67
###begin article-title 68
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Clonal and systemic analysis of long-term hematopoiesis in the mouse.
###end article-title 68
###begin article-title 69
Life span of multipotential hematopoietic stem cells in vivo.
###end article-title 69
###begin article-title 70
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation.
###end article-title 70
###begin article-title 71
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo.
###end article-title 71
###begin article-title 72
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Expansion of hematopoietic stem cells in the developing liver of a mouse embryo.
###end article-title 72
###begin article-title 73
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse.
###end article-title 73
###begin article-title 74
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Development of the mouse hematopoietic system I. Types of hemoglobin produced in embryonic yolk sac and liver.
###end article-title 74
###begin article-title 75
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Hemoglobin ontogeny during normal mouse fetal development.
###end article-title 75
###begin article-title 76
###xml 101 106 <span type="species:ncbi:9031">chick</span>
Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation.
###end article-title 76
###begin article-title 77
A common precursor for hematopoietic and endothelial cells.
###end article-title 77
###begin article-title 78
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Haemangioblast commitment is initiated in the primitive streak of the mouse embryo.
###end article-title 78
###begin article-title 79
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Ontogeny of the haematopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo.
###end article-title 79
###begin article-title 80
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Hereditary anemias of the mouse: a review for geneticists.
###end article-title 80
###begin article-title 81
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis.
###end article-title 81
###begin article-title 82
###xml 58 64 <span type="species:ncbi:10090">murine</span>
Erythroid progenitor cells and stimulating factors during murine embryonic and fetal development.
###end article-title 82
###begin article-title 83
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus.
###end article-title 83
###begin article-title 84
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Development of hematopoietic stem cell activity in the mouse embryo.
###end article-title 84
###begin article-title 85
Cell tracing shows the contribution of the yolk sac to adult haematopoiesis.
###end article-title 85
###begin article-title 86
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-kit</italic>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sup>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">41</sup>
###xml 75 81 <span type="species:ncbi:10090">murine</span>
Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting lucus: W37, Wv, W41, and W. EMBO J
###end article-title 86
###begin article-title 87
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice.
###end article-title 87
###begin article-title 88
###xml 171 177 <span type="species:ncbi:10090">murine</span>
Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo.
###end article-title 88
###begin article-title 89
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Engraftment of W/c-kit mutant mice is determined by stem cell competetion, not by increased marrow 'space'.
###end article-title 89
###begin article-title 90
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Lymphoid and erythroid repopulation in B6 W-anemic mice: a new unirradiated recipient.
###end article-title 90
###begin article-title 91
Expression and function of c-kit in hemopoietic progenitor cells.
###end article-title 91
###begin article-title 92
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
###end article-title 92
###begin article-title 93
###xml 13 19 <span type="species:ncbi:10090">murine</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Influence of murine mast cell growth factor (c-kit ligand) on colony formation by mouse marrow hematopoietic progenitor cells.
###end article-title 93
###begin article-title 94
###xml 52 58 <span type="species:ncbi:10090">murine</span>
Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors.
###end article-title 94
###begin article-title 95
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells.
###end article-title 95
###begin article-title 96
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Spleen-colony formation in anemic mice of genotype W/Wv.
###end article-title 96
###begin article-title 97
Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
###end article-title 97
###begin article-title 98
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.
###end article-title 98
###begin article-title 99
Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.
###end article-title 99
###begin article-title 100
Requirement of gp130 signaling for the AGM hematopoiesis.
###end article-title 100
###begin article-title 101
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells.
###end article-title 101
###begin article-title 102
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects.
###end article-title 102
###begin article-title 103
Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system.
###end article-title 103
###begin article-title 104
###xml 95 110 <span type="species:ncbi:10090">transgenic mice</span>
Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice.
###end article-title 104
###begin article-title 105
Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells.
###end article-title 105
###begin article-title 106
Hematopoietic commitment during embryonic stem cell differentiation in culture.
###end article-title 106
###begin article-title 107
Expression of the LIM-homeobox gene LH2 generates immortalized Steel factor-dependent multipotent hematopoietic precursors.
###end article-title 107
###begin article-title 108
Multipotent hematopoietic progenitor cells immortalized by Lhx2 self-renew by a cell nonautonomous mechanism.
###end article-title 108
###begin article-title 109
Establishment of multipotent hematopoietic progenitor cell lines from ES cells differentiated in vitro.
###end article-title 109
###begin article-title 110
Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.
###end article-title 110
###begin article-title 111
HoxB4 Confers Definitive Lymphoid-Myeloid Engraftment Potential on Embryonic Stem Cell and Yolk Sac Hematopoietic Progenitors.
###end article-title 111
###begin article-title 112
Hematopoietic progenitor/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo.
###end article-title 112
###begin article-title 113
Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression.
###end article-title 113
###begin article-title 114
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Expression pattern of the mouse T gene and its role in mesoderm formation.
###end article-title 114
###begin article-title 115
Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.
###end article-title 115
###begin article-title 116
Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential.
###end article-title 116
###begin article-title 117
Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.
###end article-title 117
###begin article-title 118
HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells.
###end article-title 118
###begin article-title 119
Embryonic stem cell-derived hematopoietic stem cells.
###end article-title 119
###begin article-title 120
Smad1 expands the hemangioblast population within a limited developmental window.
###end article-title 120
###begin article-title 121
Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid- myeloid potential.
###end article-title 121
###begin article-title 122
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Autocrine and paracrine effects of an ES-cell derived, BCR/ABL- transformed hematopoietic cell line that induces leukemia in mice.
###end article-title 122
###begin article-title 123
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse mix-like homeodomain transcription factor.
###end article-title 123
###begin article-title 124
Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.
###end article-title 124
###begin article-title 125
###xml 62 67 <span type="species:ncbi:9606">human</span>
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
###end article-title 125
###begin article-title 126
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Erythropoietin-independent erythrocyte production: Signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.
###end article-title 126
###begin article-title 127
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34+ cells through glycoprotein (gp)130 signaling.
###end article-title 127
###begin article-title 128
Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive notch1 signaling.
###end article-title 128
###begin article-title 129
Constitutively active beta-catenin promotes expansion of multipotent hematopoietic progenitors in culture.
###end article-title 129
###begin article-title 130
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development.
###end article-title 130
###begin article-title 131
Lhx2, a vertebrate homologue of apterous, regulates vertebrate limb outgrowth.
###end article-title 131
###begin article-title 132
The Lim homeobox gene Lhx2 is required for olfactory sensory neuron identity.
###end article-title 132
###begin article-title 133
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
The LIM-homeodomain protein Lhx2 is required for complete development of mouse olfactory sensory neurons.
###end article-title 133
###begin article-title 134
Lhx2 maintains stem cell character in hair follicles.
###end article-title 134
###begin article-title 135
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
###end article-title 135
###begin article-title 136
Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression.
###end article-title 136
###begin article-title 137
Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells.
###end article-title 137
###begin article-title 138
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Lhx2-/- mice develop liver fibrosis.
###end article-title 138
###begin article-title 139
Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
###end article-title 139
###begin article-title 140
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
###end article-title 140
###begin article-title 141
The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development.
###end article-title 141
###begin article-title 142
The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
###end article-title 142
###begin article-title 143
###xml 51 56 <span type="species:ncbi:9606">human</span>
Control of developmental regulators by polycomb in human embryonic stem cells.
###end article-title 143
###begin article-title 144
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Polycomb complexes repress developmental regulators in murine embryonic stem cells.
###end article-title 144
###begin article-title 145
Defined conditions for neural commitment and differentiation.
###end article-title 145
###begin article-title 146
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3.
###end article-title 146
###begin article-title 147
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5 using modified cDNA expression vectors.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Swedish Cancer Society, in part by the Swedish Medical Research Council and a grant from the Vasterbotten County. KR was supported by the Swedish Foundation for Strategic Research. LC was supported by the Tobias Foundation.
###end p 149

